APTAMER GROUP PLC — Investor Relations & Filings
Aptamer Group PLC is a life sciences company that develops custom affinity binders to address targeting challenges in research, diagnostics, and therapeutics. The company's core technology is the Optimer® platform, which discovers and develops proprietary, next-generation aptamer-based binders. These Optimer binders are engineered for high specificity, stability, and manufacturability. The company provides custom development services, partnering with global pharmaceutical, diagnostic, and biotechnology organizations to support their programs from early discovery through to clinical development. Key application areas include the development of novel therapeutics, advanced diagnostic assays, bioprocessing workflows, and biomarker discovery.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Total exemption full accounts made up to 2020-03-31 | 2021-01-17 | English | |
| Total exemption full accounts made up to 2019-03-31 | 2019-11-07 | English | |
| Total exemption full accounts made up to 2018-03-31 | 2018-12-28 | English | |
| Total exemption full accounts made up to 2017-03-31 | 2017-10-04 | English | |
| Total exemption small accounts made up to 2016-03-31 | 2016-08-16 | English | |
| [change-account-reference-date-company-current-shortened] made_up_date=2016-05-31, new_date=2016-03-31 | 2016-02-17 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2021
1 filing
| |||||
| 46830457 | Total exemption full accounts made up to 2020-03-31 | 2021-01-17 | English | ||
|
2019
1 filing
| |||||
| 46830459 | Total exemption full accounts made up to 2019-03-31 | 2019-11-07 | English | ||
|
2018
1 filing
| |||||
| 46830460 | Total exemption full accounts made up to 2018-03-31 | 2018-12-28 | English | ||
|
2017
1 filing
| |||||
| 46830461 | Total exemption full accounts made up to 2017-03-31 | 2017-10-04 | English | ||
|
2016
3 filings
| |||||
| 46830463 | Total exemption small accounts made up to 2016-03-31 | 2016-08-16 | English | ||
| 46830464 | [change-account-reference-date-company-current-shortened] made_up_date=2016-05-31, new_date=2016-03-31 | 2016-02-17 | English | ||
| 46830465 | Total exemption small accounts made up to 2015-05-31 | 2016-01-13 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for APTAMER GROUP PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
APTAMER GROUP PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7491/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7491 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7491 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7491 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7491}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APTAMER GROUP PLC (id: 7491)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.